Patents by Inventor Thomas Aaskov Pedersen

Thomas Aaskov Pedersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioassay for insulin formulations
    Patent number: 10914728
    Abstract: The invention relates to a bioassay of insulin peptide in oral formulations and low affinity insulin peptides in liquid formulations, by for quantifying phosphorylated Akt, thereby avoiding the interference of excipients in potency determination.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: February 9, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Louise Hjerrild Zeuthen, Jan Amstrup, Thomas Aaskov Pedersen
  • Bioassay for Insulin formulations
    Publication number: 20190361007
    Abstract: The invention relates to a bioassay of insulin peptide in oral formulations and low affinity insulin peptides in liquid formulations, by for quantifying phosphorylated Akt, thereby avoiding the interference of excipients in potency determination.
    Type: Application
    Filed: October 24, 2017
    Publication date: November 28, 2019
    Inventors: Louise Hjerrild Zeuthen, Jan Amstrup, Thomas Aaskov Pedersen